Risk of pancreatic adenocarcinoma in chronic pancreatitis
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Background: The risk of pancreatic cancer in patients with chronic pancreatitis (CP) is difficult to assess. Previous studies, mostly case control studies or studies relying on data case registers, reported relative risks varying from 2.3 to 18.5. Methods: We studied a prospective, single centre, medical-surgical cohort of 373 consecutive patients (322 (86%) men, median age 40 years) with proven CP (alcoholic origin 85%) and a follow up of at least two years (median follow up 9.2 years; range 2.0–34.8) in order to exclude pancreatitis revealing pancreatic cancer. We calculated the age and sex standardised incidence ratio (SIR) as the ratio of the number of observed cases of pancreatic cancer in this cohort to the number of expected cases, as provided by the French National Cancer Register. Results: Four cases of pancreatic adenocarcinoma (1.1% of patients) were observed in 3437 patient years (expected number of cases 0.15; SIR 26.7, 95% confidence interval (CI) 7.3–68.3; p=0.00002). In a second analysis in which patients lost to follow up were considered to be followed up until the end point without having developed pancreatic adenocarcinoma (4762 patient years), SIR was 19.0 (CI 5.2–48.8; p=0.00007). Conclusion: Patients with CP have a markedly increased risk of pancreatic cancer compared with the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ulcerative Colitis and Colorectal Cancer: A Population-Based Study
Ekbom, A., Helmick, C., Zack, M., & Adami, H.-O. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231802 · Cited by 1,777
Pancreatitis and the Risk of Pancreatic Cancer
Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R. W., Lankisch, P. G., Andersen, J. R., Dimagno, E. P., Andren-Sandberg, A., & Domellof, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282001 · Cited by 1,757
Hereditary Pancreatitis and the Risk of Pancreatic Cancer
Lowenfels, A. B., Maisonneuve, P., DiMagno, E. P., Elitsur, Y., Gates, L. K., Perrault, J., Whitcomb, D. C., & International Hereditary Pancreatitis Study Group (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.6.442 · Cited by 988
Rw, A., Akovbiantz, A., Largiadèr, F., et al. (1984) · PubMed · Cited by 707
Pancreatography in chronic pancreatitis: international definitions.
Axon, A. T., Classen, M., Cotton, P. B., Cremer, M., Freeny, P. C., & Lees, W. R. (1984) · Gut · doi:10.1136/gut.25.10.1107 · Cited by 451
Ulcerative colitis and colorectal cancer
Ekbom, A. (1991) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(91)90009-i · Cited by 419
Pancreas Cancer and Smoking, Beverage Consumption, and Past Medical History 2
(1986) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/76.1.49 · Cited by 362
Pancreatitis is a risk factor for pancreatic cancer
Bansal, P., & Sonnenberg, A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90291-0 · Cited by 282
Diet and other risk factors for cancer of the pancreas
Gold, E. B., Gordis, L., Diener, M. D., Seltser, R., Boitnott, J. K., Bynum, T. E., & Hutcheon, D. F. (1985) · Cancer · doi:10.1002/1097-0142(19850115)55:2<460::aid-cncr2820550229>3.0.co;2-v · Cited by 267
Alcohol and Smoking as Risk Factors in Chronic Pancreatitis and Pancreatic Cancer
Talamini, G., Bassi, C., Falconi, M., Sartori, N., Salvia, R., Rigo, L., Castagnini, A., Francesco, V. D., Frulloni, L., Bovo, P., et al. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026670911955 · Cited by 253
Cited by
Genetics and biology of pancreatic ductal adenocarcinoma
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,577
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Tempero, M. A., Malafa, M. P., Al-Hawary, M., Behrman, S. W., Benson, A. B., Cardin, D. B., Chiorean, E. G., Chung, V., Czito, B., Del Chiaro, M., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0017 · Cited by 1,304
Guerra, C., Schuhmacher, A. J., Cañamero, M., Grippo, P. J., Verdaguer, L., Pérez-Gallego, L., Dubus, P., Sandgren, E. P., & Barbacid, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.012 · Cited by 1,224
Xiao, A. Y., Tan, M. L. Y., Wu, L. M., Asrani, V. M., Windsor, J. A., Yadav, D., & Petrov, M. S. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30004-8 · Cited by 798
Epidemiology of pancreatic cancer: an overview
Raimondi, S., Maisonneuve, P., & Lowenfels, A. B. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.177 · Cited by 740
Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection
Raimondi, S., Lowenfels, A. B., Morselli-Labate, A. M., Maisonneuve, P., & Pezzilli, R. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2010.02.007 · Cited by 620
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma
Morris, J. P., Wang, S. C., & Hebrok, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2899 · Cited by 567
Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis
Kirkegård, J., Mortensen, F. V., & Cronin-Fenton, D. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.218 · Cited by 535
Guerra, C., Collado, M., Navas, C., Schuhmacher, A. J., Hernández-Porras, I., Cañamero, M., Rodriguez-Justo, M., Serrano, M., & Barbacid, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.011 · Cited by 516
“In addition, patients with chronic pancreatitis have over 10-fold increased risk of developing PDAC (Lowenfels et al., 1993; Malka et al., 2002).”
BackgroundGenetics and biology of pancreatic ductal adenocarcinoma
Ying, H., Dey, P., Yao, W., Kimmelman, A. C., Draetta, G. F., Maitra, A., & DePinho, R. A. (2016) · Genes & Development · doi:10.1101/gad.275776.115 · Cited by 527
Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study
Canto, M. I., Goggins, M., Hruban, R. H., Petersen, G. M., Giardiello, F. M., Yeo, C., Fishman, E. K., Brune, K., Axilbund, J., Griffin, C., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.02.005 · Cited by 524
Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis
Cai, J., Chen, H., Lu, M., Zhang, Y., Lu, B., You, L., Zhang, T., Dai, M., & Zhao, Y. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.06.027 · Cited by 470
Biology and management of pancreatic cancer
Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2008) · Postgraduate Medical Journal · doi:10.1136/gut.2006.103333 · Cited by 418
Morris, J. P., Cano, D. A., Sekine, S., Wang, S. C., & Hebrok, M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40045 · Cited by 366
Risk Factors for Pancreatic Cancer: Case-Control Study
Hassan, M. M., Bondy, M. L., Wolff, R. A., Abbruzzese, J. L., Vauthey, J.-N., Pisters, P. W., Evans, D. B., Khan, R., Chou, T.-H., Lenzi, R., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01510.x · Cited by 331
Advances in counselling and surveillance of patients at risk for pancreatic cancer: Table 1
Brand, R. E., Lerch, M. M., Rubinstein, W. S., Neoptolemos, J. P., Whitcomb, D. C., Hruban, R. H., Brentnall, T. A., Lynch, H. T., & Canto, M. I. (2007) · Gut · doi:10.1136/gut.2006.108456 · Cited by 323
Current standards of surgery for pancreatic cancer
Alexakis, N., Halloran, C., Raraty, M., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2004) · British Journal of Surgery · doi:10.1002/bjs.4794 · Cited by 321
Epidemiology, aetiology and outcome of acute and chronic pancreatitis: An update
Spanier, B. W. M., Dijkgraaf, M. G. W., & Bruno, M. J. (2008) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2007.10.007 · Cited by 320
Stromal biology of pancreatic cancer
Chu, G. C., Kimmelman, A. C., Hezel, A. F., & DePinho, R. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21209 · Cited by 317
Burden of Pancreatic Cancer: From Epidemiology to Practice
Khalaf, N., El-Serag, H. B., Abrams, H. R., & Thrift, A. P. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.02.054 · Cited by 308
Modifiable and non-modifiable risk factors for pancreatic cancer: A review
Midha, S., Chawla, S., & Garg, P. K. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.022 · Cited by 281
Rebours, V., Boutron-Ruault, M.-C., Schnee, M., Férec, C., Maire, F., Hammel, P., Ruszniewski, P., & Lévy, P. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01597.x · Cited by 270
Self-citationScreening for Pancreatic Cancer: Why, How, and Who?
Poruk, K. E., Firpo, M. A., Adler, D. G., & Mulvihill, S. J. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31825ffbfb · Cited by 249
Hereditary chronic pancreatitis
Rosendahl, J., Bödeker, H., Mössner, J., & Teich, N. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-1 · Cited by 225
Identification of a three-biomarker panel in urine for early detection of pancreatic adenocarcinoma
Radon, T. P., Massat, N. J., Jones, R., Alrawashdeh, W., Dumartin, L., Ennis, D., Duffy, S. W., Kocher, H. M., Pereira, S. P., Guarner (posthumous), L., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2467 · Cited by 203
“9, in identifying cancer patients among patients with CP, another risk factor for developing PDAC (8).”
BackgroundPancreatic Adenocarcinoma Clinical Practice Guidelines in Oncology
(2005) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2005.0035 · Cited by 181
Shi, G., Zhu, L., Sun, Y., Bettencourt, R., Damsz, B., Hruban, R. H., & Konieczny, S. F. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.066 · Cited by 168
Shi, G., DiRenzo, D., Qu, C., Barney, D., Miley, D., & Konieczny, S. F. (2013) · Oncogene · doi:10.1038/onc.2012.210 · Cited by 162
Kras and tumor immunity: friend or foe?
Cullis, J., Das, S., & Bar-Sagi, D. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031849 · Cited by 85
“Kras is most frequently mutated in PDAC (95%), NSCLC (35%), and colorectal cancer (CRC) (40%) tumor types that are highly associated with the inflammatory disorders pancreatitis, chronic obstructive pulmonary disorder (COPD) and smoking, and ulcerative colitis (UC), respectively (Lowenfels et al. 1993; Ahrendt et al.…”
BackgroundIn vivo reprogramming drives Kras-induced cancer development
Shibata, H., Komura, S., Yamada, Y., Sankoda, N., Tanaka, A., Ukai, T., Kabata, M., Sakurai, S., Kuze, B., Woltjen, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04449-5 · Cited by 76
Tong, T., Gu, J., Xu, D., Song, L., Zhao, Q., Cheng, F., Yuan, Z., Tian, S., Yang, X., Tian, J., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02258-8 · Cited by 77
Jeon, C. Y., Chen, Q., Yu, W., Dong, E. Y., Chung, J., Pandol, S. J., Yadav, D., Conwell, D. L., & Wu, B. U. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000147 · Cited by 23
K‐RasV14I‐induced Noonan syndrome predisposes to tumour development in mice
Hernández‐Porras, I., Schuhmacher, A. J., Garcia‐Medina, R., Jiménez, B., Cañamero, M., de Martino, A., & Guerra, C. (2016) · The Journal of Pathology · doi:10.1002/path.4719 · Cited by 16
“Chronic pancreatitis, an important risk factor for PDAC development [33,34], has been shown to cooperate with oncogenic K-Ras mutations to induce a high number of pancreatic intraepithelial neoplasias (PanINs) and PDACs [17,34].”
Background
Metadata
- Authors
- Malka, D., Hammel, P., Maire, F., Rufat, P., Madeira, I., Pessione, F., Lévy, P., & Ruszniewski, P.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2002-12
- Volume
- 51
- Issue
- 6
- Pages
- 849-852
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2137300622
- Cited by
- 457
- References
- 25
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.